Physician profile
Vikas Patel
NPI 1073870945
$1,538.19
in general payments reported to CMS, 2019-2025
7 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $33.02 · 2022: $305 · 2023: $87.25 · 2024: $939 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $719 · Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $719.03 |
| Food and Beverage | $480.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $907.28 | 2024 | Angioguard |
| Janssen Pharmaceuticals, INC | $282.01 | 2022-2024 | Xarelto |
| Alexion Pharmaceuticals, INC. | $128.63 | 2025 | Ultomiris |
| Penumbra, INC. | $101.56 | 2022 | |
| Stryker Corporation | $60.68 | 2020-2023 | Surpass Evolve |
| Medtronic, INC. | $45.05 | 2025 | Anteralign Spinal System With Titan Nanolock Surface Technology |
| E.R. Squibb & Sons, L.L.C. | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.